Figure 2 (IMAGE)

Impact Journals LLC

Figure 2

Caption

Figure 2: Abemaciclib shows greater potency than palbociclib & ribociclib in breast cancer cells.

Credit

Torres-Guzmán et. al.

Usage Restrictions

Original image

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.